Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: United States Clear all

251 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20027
20034
200411
20057
20068
200710
20087
200912
20105
20118
20126
20138
20146
20155
20168
20179
20188
20198
20208
202119
202216
202312
202412
20259
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed122
Terminated51
Recruiting34
Active, not recruiting22
Withdrawn11
Unknown status6
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)37
M.D. Anderson Cancer Center9
University of Texas Southwestern Medical Center8
Bayer7
Mayo Clinic6
Yale University6
Memorial Sloan Kettering Cancer Center5
Massachusetts General Hospital4
National Institutes of Health Clinical Center (CC)4
Northwestern University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular251
Liver Neoplasms76
Bile Duct Neoplasms19
Gallbladder Neoplasms18
Stomach Neoplasms17
Colorectal Neoplasms15
Carcinoma, Non-Small-Cell Lung14
Cholangiocarcinoma14
Neoplasms14
Melanoma12

Trials

Showing 1 to 25 of 251. Each trial links to its page on Pharma Observatory.

151 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.